EUVIMEDEUVIMED entdecken
Kommentar

Deprescribing Proton Pump Inhibitors and the Challenge of Legacy Medications

Timothy S Anderson

JAMA Internal Medicine · 01.06.2026 · 186 (6) · 656

DOI: 10.1001/jamainternmed.2026.0594 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA Internal Medicine, erschienen am 01.06.2026. Verfasst von Timothy S Anderson. Beteiligte Einrichtung: Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.
  • Associate Editor, JAMA Internal Medicine.

Zitieren

APA

Anderson, T. S. (2026). Deprescribing Proton Pump Inhibitors and the Challenge of Legacy Medications. JAMA Internal Medicine, 186(6), 656. https://doi.org/10.1001/jamainternmed.2026.0594

Vancouver

Anderson TS. Deprescribing Proton Pump Inhibitors and the Challenge of Legacy Medications. JAMA Internal Medicine. 2026;186(6):656. doi:10.1001/jamainternmed.2026.0594

BibTeX
@article{Anderson2026,
  author = {Anderson, Timothy S},
  title = {Deprescribing Proton Pump Inhibitors and the Challenge of Legacy Medications},
  journal = {JAMA Internal Medicine},
  year = {2026},
  volume = {186},
  number = {6},
  pages = {656},
  doi = {10.1001/jamainternmed.2026.0594}
}
Kostenlos starten →